InvestorsHub Logo
Followers 277
Posts 13764
Boards Moderated 0
Alias Born 02/17/2014

Re: None

Thursday, 12/08/2016 10:19:56 PM

Thursday, December 08, 2016 10:19:56 PM

Post# of 723
**TOP REASONS TO BUY PGUZ NOW**

**My NEW Pick is Pegasus Pharmaceuticals (PGUZ)**

My NEW Pick is Pegasus Pharmaceuticals (PGUZ). It's cutting edge patented technology named the HeartVue™ 6S System allows for the non-invasive screening of heart disease. Incredibly the technology provides a 3d portrait of the heart in just 60 seconds. This is a huge game changer and the CEO has confirmed that they are now working with some big pharmaceutical companies, 2 are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY), both who have invested heavily in non-invasive screening for heart pathologies. With marketing already happening in Europe the company now has filed with the FDA for approval in the US. This stock is under the radar trading sub penny but that won't last long, the CEO has hinted at big news and stated he will be providing updates shortly, NOW is the time to buy before this tiny biotech gets discovered, they could become the biggest gainer of 2016!

Trading now in sub-penny range but likely to ink a partnership or even be acquired by one of the two big pharmaceutical company they are currently working with. Now is the time to buy shares of PGUZ, don't get left behind!

Pegasus Pharmaceuticals (PGUZ) Highlights:

- An amazing share structure of just 21.6M O/S
- A float of just 5M
- Insiders own over half the float and they are NOT SELLING
-Patented game changing, revenue generating cutting edge technology that is desired by big Pharma
-CEO confirmed the company is working with some big Pharma's ( 2 of which are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY)
-Massive revenue potential, considering that in the US alone annually, approximately 635,000 Americans experience a new coronary event, 280,000 have a recurrent ischemic event, and an additional 150,000 have a silent first myocardial infarction. The ability to easily diagnosis heart disease will not only save countless lives but be incredibly lucrative, especially since the technology is patented by Pegasus Pharmaceuticals (PGUZ)


About Pegasus Pharmaceuticals (PGUZ)


Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities